2Holtl L,Zelle-Rieser C,Gander H,et al.Immunotherapy of metastatic renal cell carcinoma with tumorlysate-pulsed autologous dendritic cells[J].Clin Cancer Res,2002,8(11):3 369-3 376.
3Child R,Sproule J,Draper S,et al.Performance of a psychomotor skill following rest,exercise at the plasma epinephrine threshold and maximal intensity exercise[J].New Engl J Med,2000,343:750-758.
4Schaap N,Schattenberg A,Baer B,et al.Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions[J].Leukemia,2001,15(9):1 339-1 346.
5Dillman RO,Barth NM,Vander Molen LA,et al.Treatment of kidney cancer with autologoustumor cancer vaccines of short-term cell lines derived from renal cell carcinoma[J].Cancer Biother Radiopharm,2001,16(1):47-54.
6Hamada I.A clinical study on tumor-associated monocyte lineagecells in renal cell carcinoma[J].Acta Urologica Japonica,2002,48(4):213-220.
7Kugler A,Gernot S,Walden P,et al.Regression of human mestastatic renal cell carcinoma after vaccineation with tumor cell-dendritic cell hybride[J].Nat Med,2000,6:332-336.
8Kurokawa T,Oelke M,Mackensen A.Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells[J].International Journal of Cancer,2001,91(6):749-756.
9Brossart P,Mueller M,Brugger W,et al.Delivery of tumor derived RNA into dendritic cells for induction of cytotoxic T-cells[J].Blood,200l,98(1l part 1):51la-512a.
10Rnghoffer M,Gschwend JE.Specific cellular immunotherapy for renal cell cancer:Current state and future perspectives[J].Urology A,2002,41(3):249-257.
